Biotechnology News

REDWOOD CITY, Calif., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a pioneer in deep, unbiased proteomics, today announced that its Proteograph® Product Suite has been used by...

Exicure received a Nasdaq extension through December 2, 2026 to regain compliance with the stockholders’ equity requirement.

CLEVELAND, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing genetic medicines for serious diseases with high unmet...

Once-daily, oral ART27.13 reduced body weight by approximately 20% in obese mice, matching the weight loss achieved with semaglutide, the active ingredient in Ozempic® and Wegovy® Combining ART27.13...

諾華行使選擇權收購維泰瑞隆腦部遞送平臺 維泰瑞隆將利用交易所得持續推進三個臨床項目和多個早期項目的研發   維泰瑞隆保留使用該平臺開發選定資產的權利 麻塞諸塞州沃爾瑟姆, Sept. 16, 2026 (GLOBE NEWSWIRE) --...

诺华行使选择权收购维泰瑞隆脑部递送平台 维泰瑞隆将利用交易所得持续推进三个临床项目和多个早期项目的研发   维泰瑞隆保留使用该平台开发选定资产的权利 马萨诸塞州沃尔瑟姆, Sept. 16, 2026 (GLOBE NEWSWIRE) --...

Senior appointments add world-class expertise across gene therapy development, ophthalmology, CMC, regulatory affairs and global operations to support the next phase of growth  Carl De Luca, PhD,...

Novartis exercises option to acquire Sironax’s brain delivery platform  Sironax to advance three clinical-stage programs and multiple early-stage candidates using purchase proceeds Sironax to retain...

MILAN, Sept. 16, 2026 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), the clinical-stage biotechnology company developing genetic medicines for inherited retinal diseases (IRDs) using its...

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)